Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age2-4
SponsorHasanuddin University

About this trial

This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.

Eligibility criteria

Qualifiers

Children aged 2-4 years old at the time of enrolment

Good nutritional status with weight-for-height > -2, and height-for-age z-score > -2 based on WHO growth standards

Infants in a group setting (daycare centers).

No congenital disorder

Disqualifiers

Presence of chronic illnesses or conditions (congenital disorder, genetic syndromes, congenital heart disease, chronic renal failure, cystic fibrosis, etc)

Children who have participated in another clinical intervention study within the past 30 days.

Children who are likely to be transferred to another facility that is not part of the study before completing the follow-up period

Trial design

Treatments tested in this trial

  • a prebiotic, that us a standardized extract of cultured Lentinula edodes mycelia
  • Placebo (dextrin)

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators